Julio G. Prieto

2.8k total citations
89 papers, 2.3k citations indexed

About

Julio G. Prieto is a scholar working on Oncology, Pharmacology and Small Animals. According to data from OpenAlex, Julio G. Prieto has authored 89 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 18 papers in Pharmacology and 14 papers in Small Animals. Recurrent topics in Julio G. Prieto's work include Drug Transport and Resistance Mechanisms (31 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Helminth infection and control (14 papers). Julio G. Prieto is often cited by papers focused on Drug Transport and Resistance Mechanisms (31 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Helminth infection and control (14 papers). Julio G. Prieto collaborates with scholars based in Spain, United States and Brazil. Julio G. Prieto's co-authors include Ana I. Álvarez, Gracia Merino, Rebeca Real, Antonio J. Molina, Gracia Mendoza, Míriam Pérez, Mivis M. Pulido, Alfred H. Schinkel, Jon A. Otero and Ana Ferrando and has published in prestigious journals such as The Lancet, Blood and Journal of Agricultural and Food Chemistry.

In The Last Decade

Julio G. Prieto

88 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julio G. Prieto Spain 26 681 540 388 378 311 89 2.3k
Ana I. Álvarez Spain 29 924 1.4× 740 1.4× 509 1.3× 377 1.0× 294 0.9× 92 3.0k
Gracia Merino Spain 28 2.2k 3.2× 789 1.5× 381 1.0× 213 0.6× 392 1.3× 78 3.6k
Salah A. Sheweita Egypt 31 220 0.3× 886 1.6× 246 0.6× 201 0.5× 276 0.9× 81 3.3k
Olfat Hammam Egypt 25 265 0.4× 585 1.1× 86 0.2× 152 0.4× 429 1.4× 152 2.2k
Soon‐Cheol Ahn South Korea 32 423 0.6× 1.5k 2.8× 294 0.8× 201 0.5× 211 0.7× 127 3.3k
Jiang Zheng China 30 158 0.2× 627 1.2× 163 0.4× 76 0.2× 116 0.4× 90 2.8k
N. R. Di Luzio United States 35 244 0.4× 755 1.4× 256 0.7× 566 1.5× 273 0.9× 141 4.0k
Asima Bhattacharyya India 24 309 0.5× 1.4k 2.7× 151 0.4× 174 0.5× 676 2.2× 47 3.8k
Ihor Bekersky United States 32 681 1.0× 310 0.6× 521 1.3× 50 0.1× 494 1.6× 69 3.7k
Xiaofei Xu China 25 432 0.6× 1.1k 2.1× 506 1.3× 70 0.2× 198 0.6× 64 2.9k

Countries citing papers authored by Julio G. Prieto

Since Specialization
Citations

This map shows the geographic impact of Julio G. Prieto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio G. Prieto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio G. Prieto more than expected).

Fields of papers citing papers by Julio G. Prieto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julio G. Prieto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio G. Prieto. The network helps show where Julio G. Prieto may publish in the future.

Co-authorship network of co-authors of Julio G. Prieto

This figure shows the co-authorship network connecting the top 25 collaborators of Julio G. Prieto. A scholar is included among the top collaborators of Julio G. Prieto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julio G. Prieto. Julio G. Prieto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miguel, Verónica, Jon A. Otero, Idania Rodeiro, et al.. (2015). ABCG2/BCRP interaction with the sea grass Thalassia testudinum. Drug Metabolism and Personalized Therapy. 30(4). 251–256. 1 indexed citations
2.
Moreno‐Sanz, Guillermo, Andrea Armirotti, Sine Mandrup Bertozzi, et al.. (2014). Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain. Pharmacological Research. 87. 87–93. 8 indexed citations
3.
Otero, Jon A., A. de la Fuente, Julio G. Prieto, et al.. (2014). Short communication: The gain-of-function Y581S polymorphism of the ABCG2 transporter increases secretion into milk of danofloxacin at the therapeutic dose for mastitis treatment. Journal of Dairy Science. 98(1). 312–317. 20 indexed citations
5.
Pérez, Míriam, et al.. (2012). Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: Effect on plasma and milk levels of danofloxacin in sheep. The Veterinary Journal. 196(2). 203–208. 37 indexed citations
6.
7.
Alou, Luís, María-José Giménez, Fabio Cafini, et al.. (2009). In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline. Journal of Antimicrobial Chemotherapy. 64(6). 1230–1233. 9 indexed citations
8.
Merino, Gracia, Rebeca Real, Marta Baro, et al.. (2008). Natural Allelic Variants of Bovine ATP-Binding Cassette Transporter ABCG2: Increased Activity of the Ser581 Variant and Development of Tools for the Discovery of New ABCG2 Inhibitors. Drug Metabolism and Disposition. 37(1). 5–9. 20 indexed citations
9.
Aguilar, L., José Barberán, Julio G. Prieto, & María-José Giménez. (2008). Optimización de la actividad bactericida en el tratamiento hospitalario de infecciones por grampositivos. Revista española de quimioterapia. Suplemento. 21(1). 37–44. 2 indexed citations
10.
Aguilar, L., et al.. (2007). Isolation of Legionella species/serogroups from water cooling systems compared with potable water systems in Spanish healthcare facilities. Journal of Hospital Infection. 67(4). 360–366. 26 indexed citations
11.
Huelves, Lorena, David Sevillano, Matilde Gracia, et al.. (2006). Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones. International Journal of Antimicrobial Agents. 27(4). 294–299. 8 indexed citations
12.
Álvarez, Ana I., Gracia Merino, Antonio J. Molina, et al.. (2006). Role of ABC Transporters in Veterinary Drug Research and Parasite Resistance. Current Drug Delivery. 3(2). 199–206. 32 indexed citations
13.
Molina, Antonio J., Julio G. Prieto, Gracia Merino, et al.. (2006). Effects of ischemia–reperfusion on the absorption and esterase metabolism of diltiazem in rat intestine. Life Sciences. 80(5). 397–407. 10 indexed citations
14.
Oliveira, Ana Cristina, Andréa C. Perez, Julio G. Prieto, Igor Dimitri Gama Duarte, & Ana I. Álvarez. (2005). Protection of Panax ginseng in injured muscles after eccentric exercise. Journal of Ethnopharmacology. 97(2). 211–214. 24 indexed citations
15.
Virkel, G., F. Imperiale, A. Lifschitz, et al.. (2003). Effect of amphiphilic surfactant agents on the gastrointestinal absorption of albendazole in cattle. Biopharmaceutics & Drug Disposition. 24(3). 95–103. 4 indexed citations
16.
Merino, Gracia, Ana I. Álvarez, Julio G. Prieto, & Richard B. Kim. (2002). The Anthelminthic Agent Albendazole Does Not Interact with P-Glycoprotein. Drug Metabolism and Disposition. 30(4). 365–369. 38 indexed citations
18.
Merino, Gracia, et al.. (1999). Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministration.. Research in Veterinary Science. 66(3). 281–283. 5 indexed citations
19.
Álvarez, Ana I., et al.. (1993). Effects of stanozolol and L-carnitine on erythrocyte osmotic fragility during aerobic exercise in rats. 3(4). 196–200. 3 indexed citations
20.
Salto, Francisco & Julio G. Prieto. (1981). Interactions of Cephalosporins and Penicillins with Nonpolar Macroporous Styrenedivinylbenzene Copolymers. Journal of Pharmaceutical Sciences. 70(9). 994–998. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026